Log in or Sign up for Free to view tailored content for your specialty!
Mood Disorders News
Low-income Black women with uncontrolled hypertension at increased risk for depression
More than half of low-income African American women with uncontrolled hypertension had symptoms of depression, according to results of a secondary analysis of a randomized clinical trial published in JAMA Psychiatry.
Short sleep duration intensifies effects of frailty on depressive symptoms
Short sleep duration appeared to increase the effects of frailty on depressive symptoms, according to results of a prospective cohort study published in Journal of the American Geriatrics Society.
Log in or Sign up for Free to view tailored content for your specialty!
European Commission authorizes Spravato for rapid reduction of depressive symptoms in MDD
The Janssen Pharmaceutical Companies of Johnson & Johnson have announced European Commission authorization of expanded use of its esketamine nasal spray Spravato among adults with a moderate to severe episode of major depressive disorder.
COVID-19-related mental health, substance use disparities differ by race, ethnicity
Combined prevalence estimates of depression, initiating or increasing substance use and suicidal thoughts/ideation among U.S. adults have been significant during the COVID-19 pandemic, researchers noted in MMWR.
Nonspecialist-delivered perinatal mental health interventions effective
Nonspecialist providers appeared to be effective in the prevention and treatment of perinatal depressive and anxiety symptoms in high-income countries, according to results of a systematic review and meta-analysis published in JAMA Psychiatry.
Top psych stories of January: Mental health of COVID-19 health care workers and more
Healio Psychiatry has compiled a list of its five most-viewed stories in January.
Cannabis use disorder a risk marker for self-harm among youths with mood disorders
Cannabis use disorder was associated with self-harm, all-cause mortality, unintentional overdose death and homicide among youth with mood disorders, according to a study published in JAMA Pediatrics.
Schizophrenia diagnosis among top risk factors for mortality in COVID-19 patients
Schizophrenia spectrum disorder diagnosis appeared to be a significant risk factor for mortality among individuals with COVID-19, according to results of a retrospective cohort study published in JAMA Psychiatry.
Acute, maintenance citalopram treatment did not benefit patients with bipolar depression
Citalopram combined with standard mood stabilizers did not offer clinically meaningful benefit vs. placebo for acute or maintenance treatment of bipolar depression, according to study results published in Journal of Clinical Psychiatry.
Chronobiological alterations tied to passive, active suicidal ideation and preparation
Chronobiological alterations appeared directly linked to passive and active suicidal ideation and preparation, according to study results published in Journal of Clinical Psychiatry.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read